Shandong Aishi Biotechnology
Ipamorelin
Finnrick tested 4 samples of Ipamorelin (GHS agonist) from Shandong Aishi Biotechnology between 11 Dec 2025 and 6 May 2026. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Shandong Aishi Biotechnology
Ipamorelin
Tested 4 Samples
Last test 6 May 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Ipamorelin tests from top-rated vendors:
All Ipamorelin tests from Shandong Aishi Biotechnology
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
6 May 2026
First
11 Dec 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 6 May 2026 | View | 5mg | 4.83mg | -3.4% | 99.90% | February 2,2026 | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 2 Feb 2026 | View | 10mg | 9.8mg | -2.0% | 99.90% | Dec, 2, 2025 | No Label / Silver Crimp / Clear Green Cap | Lab E | Public | |
| 22 Jan 2026 | View | 10mg | 9.7mg | -3.0% | 99.80% | AS251206 | No Label / Silver Crimp / Clear Green Cap | Lab G | Public | |
| 11 Dec 2025 | View | 10mg | 11.1mg | +11.0% | 99.91% | Nov. 2 2025 | No Label / Silver Crimp / Clear Green Cap | Lab E | Public | |